BioCorRx Inc.
BICX
$0.36
$0.025.88%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 31.97% | -20.25% | -71.70% | -31.97% | -22.49% |
| Total Depreciation and Amortization | 3.90% | -74.11% | -58.07% | -38.20% | -10.00% |
| Total Amortization of Deferred Charges | -43.44% | -1.50% | 46.79% | 183.96% | 112.10% |
| Total Other Non-Cash Items | 46.71% | 713.23% | 757.16% | -13.72% | 56.29% |
| Change in Net Operating Assets | -191.13% | 338.03% | -16.85% | 691.96% | 19.85% |
| Cash from Operations | -103.00% | 53.69% | -2.00% | 73.42% | 14.52% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 68.42% | -21.14% | 15.68% | 11,800.00% | 61.47% |
| Total Debt Repaid | -1,750.00% | -500.00% | -3,033.33% | 98.87% | -33.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 66.63% | -24.29% | 12.79% | -89.53% | -29.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -277.99% | 196.38% | 79.71% | -1,348.44% | -73.43% |